Elizabeth Kessler, MD
Associate Professor, Medicine-Medical Oncology

Photo
Medical School:
  • MD, New York Medical College (2006)
Undergraduate School:
  • BS, University of Colorado - Boulder (CO) (2000)
Residency:
  • University of Colorado (University Hospital) Program, Internal Medicine (2010)
Fellowships:
  • University of Colorado, Hematology and Oncology (2013)
Languages: English
Department: Medicine-Medical Oncology

Professional Titles

  • Assistant Professor of Medical Oncology

Recognition & Awards

  • American Society of Clinical Oncology Young Investigator Award, ASCO (2013)
  • Hartford Scholar, The Hartford Foundation (2013)

Research Interests

I am interested in translational and clinical research in genitourinary cancers as well as in research within supportive oncology. I focus on improving the care of older patients with GU cancers with a focus on the impact of treatment on functional outcomes. I also am interested in improvement of therapies for GU cancers with a focus on how treatment impacts metabolism and physical function.

Publications

  • Margulis V, Puligandla M, Trabulsi EJ, Plimack ER, Kessler ER, Matin SF, Godoy G, Alva A, Hahn NM, Carducci MA, Hoffman-Censits J. Reply by Authors. J Urol. 2020 Jan 22;:101097JU000000000000064402. [Epub ahead of print] PubMed PMID: 31967495
  • Chan JM, Van Blarigan EL, Langlais CS, Zhao S, Ramsdill JW, Daniel K, Macaire G, Wang E, Paich K, Kessler ER, Beer TM, Lyons KS, Broering JM, Carroll PR, Kenfield SA, Winters-Stone KM. Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial. J Med Internet Res. 2020 Dec 31;22(12):e19238. PubMed PMID: 33382378
  • Wang EY, Graff RE, Chan JM, Langlais CS, Broering JM, Ramsdill JW, Kessler ER, Winters-Stone KM, Van Blarigan EL, Kenfield SA. Web-Based Lifestyle Interventions for Prostate Cancer Survivors: Qualitative Study. JMIR Cancer. 2020 Nov 10;6(2):e19362. PubMed PMID: 33170126
  • Boxley PJ, Smith DE, Gao D, Kessler ER, Echalier B, Bernard B, Ormond DR, Lam ET, Kavanagh BD, Flaig TW. Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort. Clin Genitourin Cancer. 2020 Aug 22. [Epub ahead of print] PubMed PMID: 33069585
  • Kessler ER, Kukreja JB, Geiger CL, Fischer SM. Treating Elderly Patients With Muscle-Invasive Bladder Cancer. J Natl Compr Canc Netw. 2020 Jun;18(6):783-790. PubMed PMID: 32502977
  • Hsu T, Kessler ER, Parker IR, Dale W, Gajra A, Holmes HM, Maggiore RJ, Magnuson A, McKoy JM, Hurria A. Identifying Geriatric Oncology Competencies for Medical Oncology Trainees: A Modified Delphi Consensus Study. Oncologist. 2020 Jul;25(7):591-597. PubMed PMID: 32237179
  • Margulis V, Puligandla M, Trabulsi EJ, Plimack ER, Kessler ER, Matin SF, Godoy G, Alva A, Hahn NM, Carducci MA, Hoffman-Censits J. Reply by Authors. J Urol. 2020 Apr;203(4):697-698. PubMed PMID: 31967495
  • Margulis V, Puligandla M, Trabulsi EJ, Plimack ER, Kessler ER, Matin SF, Godoy G, Alva A, Hahn NM, Carducci MA, Hoffman-Censits J. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma. J Urol. 2020 Apr;203(4):690-698. PubMed PMID: 31702432
  • Margulis V, Puligandla M, Trabulsi EJ, Plimack ER, Kessler ER, Matin SF, Godoy G, Alva A, Hahn NM, Carducci MA, Hoffman-Censits J. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma. J Urol. 2019 Nov 8;:101097JU0000000000000644. [Epub ahead of print] PubMed PMID: 31702432
  • Hahn AW, Stenehjem DD, Alex AB, Gill DM, Cheng HH, Kessler ER, Chittoria N, Twardowski P, Vaishampayan U, Agarwal N. Time from definitive therapy to onset of metastatic disease predicts outcomes in men with metastatic hormone sensitive prostate cancer. Urol Oncol. 2019 Jun;37(6):352.e19-352.e24. PubMed PMID: 30770300
  • Duarte C, Jimeno A, Kessler ER. Abiraterone acetate to treat metastatic castration-resistant prostate cancer in combination with prednisone. Drugs Today (Barc). 2019 Jan;55(1):5-15. PubMed PMID: 30740608
  • Walker JP, Saltzman AF, Kessler ER, Cost NG. Adult Wilms Tumor During Pregnancy: Case Report and Literature Review. Urology. 2019 Jul;129:200-205. PubMed PMID: 30597169
  • Kessler ER, Gao D, Flaig TW, Breaker K, Wold M, Wacker M, Lam ET. Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate. Ann Oncol. 2017 Feb 14. [Epub ahead of print] PubMed PMID: 28203770
  • Stokes W, Amini A, Maroni PD, Kessler ER, Stokes C, Cost CR, Greffe BS, Garrington TP, Liu AK, Cost NG. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis. J Pediatr Urol. 2017 Jan 17. [Epub ahead of print] PubMed PMID: 28153774
  • Neuwelt AJ, Mathur S, Johnson AT, Kessler ER, Bowles DW. Cabozantinib use in renal cell carcinoma. Drugs Today (Barc). 2017 May;53(5):299-307. PubMed PMID: 28650002
  • Kessler ER, Gao D, Flaig TW, Breaker K, Wold M, Wacker M, Lam ET. Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate. Ann Oncol. 2017 Mar 1;28(3):668. PubMed PMID: 28426121
  • Amini A, Raben D, Crawford ED, Flaig TW, Kessler ER, Lam ET, Maroni P, Pugh TJ. Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database. Urol Oncol. 2017 Jun;35(6):438-446. PubMed PMID: 28214281
  • Stokes W, Amini A, Maroni PD, Kessler ER, Stokes C, Cost CR, Greffe BS, Garrington TP, Liu AK, Cost NG. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis. J Pediatr Urol. 2017 Aug;13(4):386.e1-386.e7. PubMed PMID: 28153774
  • Kessler ER. What is behind the flare phenomenon?. BJU Int. 2016 Dec;118(6):845-846. PubMed PMID: 27870361
  • Loh KP, Mohile SG, Kessler E, Fung C. Treatment of Metastatic Prostate Cancer in Older Adults. Curr Oncol Rep. 2016 Oct;18(10):63. PubMed PMID: 27586377
  • Amini A, Waxweiler TV, Maroni PD, Kessler ER, Cost CR, Greffe BS, Garrington TP, Liu AK, Cost NG. Survival outcomes of adolescent and adult patients with non-seminomatous testicular germ-cell tumors: A population-based study. J Pediatr Urol. 2016 Dec;12(6):405.e1-405.e9. PubMed PMID: 27544905
  • Kessler ER, Eckhardt SG, Pitts TM, Bradshaw-Pierce EL, O'byrant CL, Messersmith WA, Nallapreddy S, Weekes C, Spratlin J, Lieu CH, Kane MA, Eppers S, Freas E, Leong S. Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers. Invest New Drugs. 2016 Apr;34(2):176-83. PubMed PMID: 26715573
  • Kessler E. Capsule commentary on tomko et Al., a comparison of web- versus print-based decision AIDS for prostate cancer screening: participants' evaluation and utilization. J Gen Intern Med. 2015 Jan;30(1):94. PubMed PMID: 25266409
  • Kessler ER, Eckhardt SG, Pitts TM, Bradshaw-Pierce EL, O'byrant CL, Messersmith WA, Nallapreddy S, Weekes C, Spratlin J, Lieu CH, Kane MA, Eppers S, Freas E, Leong S. Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers. Invest New Drugs. 2015 Dec 30. [Epub ahead of print] PubMed PMID: 26715573
  • Altoos B, Amini A, Yacoub M, Bourlon MT, Kessler EE, Flaig TW, Fisher CM, Kavanagh BD, Lam ET, Karam SD. Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT). Radiat Oncol. 2015 Oct 28;10:218. PubMed PMID: 26510665
  • Amini A, Altoos B, Bourlon MT, Bedrick E, Bhatia S, Kessler ER, Flaig TW, Fisher CM, Kavanagh BD, Lam ET, Karam SD. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?. Pract Radiat Oncol. 2015 Nov-Dec;5(6):e589-96. PubMed PMID: 26142027
  • Kessler ER, Amini A, Wilson SS, Anp-C KB, Raben D, La Rosa FG, Crawford ED. Lymphoepithelioma-Like Carcinoma of the Urinary Bladder. Oncology (Williston Park). 2015 Jun;29(6):462, C3. PubMed PMID: 26089221
  • Kessler E. Capsule commentary on Tomko et al., A comparison of web- versus print-based decision AIDS for prostate cancer screening: participants' evaluation and utilization. J Gen Intern Med. 2015 Jan;30(1):94. PubMed PMID: 25266409
  • Bourlon MT, Kessler ER. What next? Choosing second-line therapy in progressive renal cell carcinoma. Oncology (Williston Park). 2014 Sep;28(9). PubMed PMID: 25225803
  • Kessler ER, Moss A, Eckhardt SG, Laudenslager ML, Kilbourn K, Mauss IB, Bowles DW, Hecker S, Fairclough DL, Kutner JS. Distress among caregivers of phase I trial participants: a cross-sectional study. Support Care Cancer. 2014 Dec;22(12):3331-40. PubMed PMID: 25120010
  • Kessler ER, Flaig TW. Geriatric considerations in the treatment of advanced prostate cancer. F1000Prime Rep. 2014;6:33. PubMed PMID: 24860655
  • Bourlon MT, Kessler ER. What next? Choosing second-line therapy in progressive renal cell carcinoma. Oncology (Williston Park). 2014 Sep;28(9):794-6. PubMed PMID: 25225803
  • Kessler ER, Moss A, Eckhardt SG, Laudenslager ML, Kilbourn K, Mauss IB, Bowles DW, Hecker S, Fairclough DL, Kutner JS. Distress among caregivers of phase I trial participants: a cross-sectional study. Support Care Cancer. 2014 Dec;22(12):3331-40. PubMed PMID: 25120010
  • Lam ET, Kessler ER, Flaig TW, La Rosa FG. Collision renal cell papillary and medullary carcinoma in a 66-year-old man. Oncology (Williston Park). 2013 Sep;27(9):893, 896, 898. PubMed PMID: 24282987
  • Verdoorn BP, Kessler ER, Flaig TW. Targeted therapy in advanced urothelial carcinoma. Oncology (Williston Park). 2013 Mar;27(3):219-26. PubMed PMID: 23687793
  • Yang X, La Rosa FG, Genova EE, Huber K, Schaack J, Degregori J, Serkova NJ, Li Y, Su LJ, Kessler E, Flaig TW. Simultaneous activation of Kras and inactivation of p53 induces soft tissue sarcoma and bladder urothelial hyperplasia. PLoS One. 2013;8(9):e74809. PubMed PMID: 24058630
  • Yang X, Kessler E, Su LJ, Thorburn A, Frankel AE, Li Y, La Rosa FG, Shen J, Li CY, Varella-Garcia M, Glodé LM, Flaig TW. Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer. Clin Cancer Res. 2013 Jan 1;19(1):148-57. PubMed PMID: 23172881
View All (37 Total) View Less

Practice Locations

UCH - Cancer Center
1665 Aurora Ct
Aurora, CO 80045
720-848-0300

UCHealth Tony Grampsas Urologic Cancer Care Clinic - Anschutz Medical Campus
1665 Aurora Ct
1st Floor
Aurora, CO 80045
720-848-0170

Hospital Affiliation
  • University of Colorado Hospital
Center Affiliations

Specialty Information

Specialties
  • Internal Medicine, Board Certification (2009)
  • Medical Oncology, Board Certification (2013)
  • Hematology and Oncology
Conditions & Treatments
  • Cancers - Bladder Cancer
  • Cancers - Prostate Cancer
  • Cancers - Kidney Cancer
  • Cancers - Testicular Cancer
  • Cancers - Urologic Cancer
  • Cancers
Care Philosophy
I am interested in Genitourinary Cancers (Prostate, Bladder, Testicular and Kidney Cancers). We strive to provide patient-focused, personalized, multi-disciplinary care for genitourinary (GU) cancers. Our specialized providers in Medical Oncology (chemotherapy and targeted therapies), Urologic Oncology, Radiation Oncology, Pathology, Molecular Pathology, Radiology, Interventional Radiology, Nuclear Medicine, Nutrition, and Integrative Medicine work together to achieve the best outcomes for our patients. We have weekly GU cancer tumor boards, where our specialists come together to discuss patients and patient care.

General Information

Medical Schools:
  • MD, New York Medical College (2006)
Undergraduate Schools:
  • BS, University of Colorado - Boulder (CO) (2000)
Residency Programs:
  • University of Colorado (University Hospital) Program, Internal Medicine (2010)
Fellowships:
  • University of Colorado, Hematology and Oncology (2013)
Languages: English
Department: Medicine-Medical Oncology
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;